Endoscopic Ruler for the Assessment of Variceal Bleeding Risks (CHESS2005)

April 23, 2023 updated by: Xiaolong Qi, Hepatopancreatobiliary Surgery Institute of Gansu Province

Endoscopic Ruler for the Assessment of Variceal Bleeding Risks in Portal Hypertension (CHESS2005): A Prospective Multicenter Trial

The presence of varices is a serious complication of portal hypertension in liver disease. To prevent variceal haemorrhage, screening and surveillance aims to detect high-risk varices related to varices size and determine the need for primary prophylaxis. Varices size evaluated by endoscopists might not be perfect reference, influenced by experience and machine. Endoscopic ruler is a novel tool to measure the varices size under the endoscopy. The investigators aim to evaluate the bias of varices size between endoscopists and endoscopic ruler as the reference.

Study Overview

Study Type

Observational

Enrollment (Anticipated)

266

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

      • Baotou, China
        • Not yet recruiting
        • The Second Affiliated Hospital of Baotou Medical College
        • Contact:
          • Xianmei Meng, M.D.
      • Changsha, China
        • Not yet recruiting
        • The Third Xiangya Hospital of Central South University
        • Contact:
          • Xiaoyan Wang, M.D.
      • Lanzhou, China
        • Not yet recruiting
        • The First Hospital of Lanzhou University
        • Contact:
          • Xiaolong Qi, M.D.
      • Nanjing, China
        • Not yet recruiting
        • The First Affiliated Hospital with Nanjing Medical University
        • Contact:
          • Guoxin Zhang, M.D.
      • Shijiazhuang, China
        • Not yet recruiting
        • The Second Hospital of Hebei Medical University
        • Contact:
          • Zhijie Feng, M.D.
      • Tianjin, China
        • Not yet recruiting
        • Tianjin Second People's Hospital
        • Contact:
          • Fengmei Wang, M.D.
      • Yinchuan, China
        • Recruiting
        • People's Hospital of Ningxia Hui Autonomous Region
        • Contact:
          • Shengjuan Hu, M.D.

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 75 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Sampling Method

Probability Sample

Study Population

The investigators prospectively recruit well-defined participants with liver cirrhosis from university hospitals. Esophagogastroduodenoscopy is performed by a dedicated endoscopist at each center. Varices size is evaluated by the endoscopist and endoscopic ruler.

Description

Inclusion Criteria:

  • age between 18 and 75 years
  • clinically evident or biopsy-confirmed cirrhosis
  • Varices diagnosed by endoscopy
  • written informed consent

Exclusion Criteria:

  • red sign
  • Active upper gastrointestinal bleeding

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Overall eligible participants
Eligible participants whose varix size will be measured by endoscopists and endoscopic ruler will receive standard esophagogastroduodenoscopy

Endoscopic ruler for varices in portal hypertension

Product uses: measuring the diameter of the veins under the endoscopy for the assessment of the risk of variceal haemorrhage in patients with portal hypertension

Black and white measuring rule is highly recognizable under the endoscopy

The width of each cell is 1 mm, and the measuring range is 0-10 mm

With smooth edge, safe and reliable

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
The intraclass correlation coefficient (ICC) of the varix size and the kappa value of the varices bleeding risk between endoscopists and endoscopic ruler
Time Frame: 2020/11/13-2022/11/13
2020/11/13-2022/11/13

Secondary Outcome Measures

Outcome Measure
Time Frame
The ICC value of the varix size and the kappa value of the varices bleeding risk among endoscopists
Time Frame: 2020/11/13-2022/11/13
2020/11/13-2022/11/13
The bleeding rate of endoscopic ruler
Time Frame: 2020/11/13-2022/11/13
2020/11/13-2022/11/13
The timing of endoscopic ruler
Time Frame: 2020/11/13-2022/11/13
2020/11/13-2022/11/13
The correlation coefficient between varices size and hepatic venous pressure gradient
Time Frame: 2020/11/13-2022/11/13
2020/11/13-2022/11/13
The correlation coefficient between varices size and decompensated events
Time Frame: 2020/11/13-2022/11/13
2020/11/13-2022/11/13

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

December 23, 2020

Primary Completion (Actual)

April 1, 2023

Study Completion (Anticipated)

January 1, 2025

Study Registration Dates

First Submitted

November 15, 2020

First Submitted That Met QC Criteria

November 19, 2020

First Posted (Actual)

November 20, 2020

Study Record Updates

Last Update Posted (Actual)

April 25, 2023

Last Update Submitted That Met QC Criteria

April 23, 2023

Last Verified

April 1, 2023

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Liver Cirrhosis

Clinical Trials on Endoscopic ruler

3
Subscribe